Anti-aids cocktail consisting of an anti-tumoral compound, a p-glycoprotein inhibitor, and an anti-viral agent
AssigneeArion Tecnologia Brazil - GestäO De Ativos S/A
InventorGerson SILVA PAIVA
Life of this patent
Estimating the term…
Abstract
The invention relates to a cocktail against Aids, consisting of a commercially available anti-tumoral drug (1), such as doxorubicin, idarubicin, etoposide, chlorambucil, cisplatin, melphalan or bortezomib, a P-glycoprotein inhibitor (2), such as tariquidar, cetoconazol, verapamil, amiodarone or quinidine, and a commercially available antiviral agent of the viricidal type (3) which acts directly on the virus, such as N,N-dichloro-2,2-dimethyltaurine (NVC-422) or the HIVcide nanoviricide, and designed to combat and completely eliminate the Aids virus from the organism.
Claims4
An anti-Aids cocktail comprising an anti-tumoral compound, a p-glycoprotein inhibitor and an anti-viral agent, characterized in that it is a cocktail comprising the combination of an anti-tumoral medicament, an inhibitor of glycoprotein P, and an antiviral agent of the type viricide, all known commercially and administered M their recommended doses.
Dependencies are inferred from the claim text.